- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Top U.K. Biomedical Center to Move
14 February 2005 (All day)
One of the United Kingdom's top biomedical centers will have to abandon its green, suburban campus outside London and squeeze into a new site in the city's center, according to a decision by a government funding agency. The National Institute for Medical Research (NIMR), currently located on a 47-acre site in suburban Mill Hill, will relocate to University College London (UCL). Researchers at the institute have battled such a move for over a year.
The relocation represents a "unanimous decision" by the Medical Research Council (MRC), the government funding agency which funds the center, according to an MRC statement on 11 February. The MRC chiefs had long argued that the suburban institute should sit alongside a central medical school and hospital to advance "translational research" (Science, 4 February, p. 652).
Scientists at NIMR, which has a staff of more than 700, had resisted the planned move. Their concerns included cuts in staff due to the costs of relocation, smaller animal facilities, and a loss of the institute's independence.
Malcolm Grant, president and Provost of UCL, immediately set out to reassure the scientists, noting that the university already has strong collaborations with them. But there are still "a number of hurdles to be cleared" before the relocation can occur, Grant concedes. The project must win a large amount of government funding and be approved for extensive renovation of buildings in the city. Grant also fears UCL may not be able to duplicate one of the unique advantages the institute now enjoys—a category 4 biosafety research lab.